Potency and coagulation factor effects of 2,3,5,6-tetrachloro-4-pyridinol compared to warfarin and its antagonism by vitamin K.
D000438:Alcohols / Q000008:administration & dosage / Q000037:antagonists & inhibitors; D000818:Animals; D000925:Anticoagulants / Q000008:administration & dosage / Q000037:antagonists & inhibitors*; D001777:Blood Coagulation / Q000187:drug effects*; D002713:Chlorine / Q000008:administration & dosage / Q000037:antagonists & inhibitors; D004285:Dogs; D005164:Factor IX / Q000037:antagonists & inhibitors; D005165:Factor V / Q000037:antagonists & inhibitors; D005167:Factor VII / Q000037:antagonists & inhibitors; D005170:Factor X / Q000037:antagonists & inhibitors; D005340:Fibrinogen / Q000032:analysis; D008297:Male; D011517:Prothrombin Time; D011725:Pyridines / Q000008:administration & dosage / Q000037:antagonists & inhibitors*; D051381:Rats; D013997:Time Factors; D014812:Vitamin K / Q000494:pharmacology; D010837:Vitamin K 1 / Q000494:pharmacology; D014859:Warfarin / Q000008:administration & dosage / Q000494:pharmacology*
D000438:Alcohols; D000925:Anticoagulants; D011725:Pyridines; D014812:Vitamin K; D002713:Chlorine; D014859:Warfarin; D010837:Vitamin K 1; D005165:Factor V; D005167:Factor VII; D005164:Factor IX; D005170:Factor X; D005340:Fibrinogen